{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:58:16Z","timestamp":1769741896721,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Biotechnology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1016\/s0958-1669(01)00271-3","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T10:28:09Z","timestamp":1027592889000},"page":"626-631","source":"Crossref","is-referenced-by-count":43,"title":["In vivo drug target discovery: identifying the best targets from the genome"],"prefix":"10.1016","volume":"12","author":[{"given":"D.Wade","family":"Walke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunsheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Wann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Zambrowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Sands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0958-1669(01)00271-3_BIB1","first-page":"398","article-title":"Too many targets, not enough target validation","volume":"6","author":"Syzmkowski","year":"2001","journal-title":"Drug Discov Today"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB2","unstructured":"Boston Consulting Group: A revolution in R&D: the impact of genomics. BCG Focus. Boston, MA: Boston Consulting Group, 2001:1-15."},{"key":"10.1016\/S0958-1669(01)00271-3_BIB3","series-title":"The impact of genomics on drug development. Lehman-McKinsey Study","author":"McKinsey","year":"2001"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1359-6446(01)01794-9","article-title":"Transgenic knockouts as part of high-throughput, evidence-based target selection and validation strategies","volume":"6","author":"Harris","year":"2001","journal-title":"Drug Discov Today"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB5","first-page":"8","article-title":"Generating mice with targeted mutations","volume":"7","author":"Evans","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1359-6101(00)00032-0","article-title":"The interferon system and interferon regulatory factor transcription factors \u2014 studies from gene knockout mice","volume":"12","author":"Sato","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0027-5107(98)00018-9","article-title":"Murine tumor suppressor models","volume":"400","author":"Venkatachalam","year":"1998","journal-title":"Mutat Res"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130000573","article-title":"Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice","volume":"155","author":"Gingrich","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0149-7634(01)00003-3","article-title":"KOs and organisation of peptidergic feeding behavior mechanisms","volume":"25","author":"Beck","year":"2001","journal-title":"Neurosci Biobehav"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2741\/Fazio","article-title":"Mouse models of hyperlipidemia and atherosclerosis","volume":"6","author":"Fazio","year":"2001","journal-title":"Front Biosci"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1146\/annurev.genet.34.1.687","article-title":"Genetic models of obesity and energy balance in the mouse","volume":"34","author":"Robinson","year":"2000","journal-title":"Annu Rev Genet"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB13","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The sequence of the human genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB14","unstructured":"National Center for Biotechnology Information: Publicly funded programs in sequencing the mouse genome. URL: http:\/\/www.ncbi.nlm.nih.gov\/Traces\/traces.cgi 2001. The rapid advances in mouse genome sequencing are facilitating mouse reverse genetic strategies."},{"key":"10.1016\/S0958-1669(01)00271-3_BIB15","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2144\/99266rr02","article-title":"Construction of gene targeting vectors from \u03bbKOS genomic libraries","volume":"26","author":"Wattler","year":"1999","journal-title":"Biotechniques"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/33423","article-title":"Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells","volume":"392","author":"Zambrowicz","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB17","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/hmg\/8.10.1839","article-title":"Osteopetrosis and osteoporosis: two sides of the same coin","volume":"8","author":"Lazner","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1381612003401569","article-title":"Cathepsin Kl: cathepsin K and the design of inhibitors of cathepsin K","volume":"6","author":"Yamashita","year":"2000","journal-title":"Curr Pharm Des"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB19","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","article-title":"Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice","volume":"95","author":"Saftig","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(00)81865-6","article-title":"Targeted disruption of the melanocortin-4 receptor results in obesity in mice","volume":"88","author":"Huszar","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/79254","article-title":"Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass","volume":"26","author":"Chen","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1008983615045","article-title":"Role of the melanocortin-4 receptor in metabolic rate and food intake in mice","volume":"9","author":"Chen","year":"2000","journal-title":"Transgenic Res"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB23","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1101\/gad.892001","article-title":"The lac operator\u2013repressor system is functional in the mouse","volume":"15","author":"Cronin","year":"2001","journal-title":"Gen Dev"},{"key":"10.1016\/S0958-1669(01)00271-3_BIB24","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1126\/science.1056843","article-title":"Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2","volume":"291","author":"Abu-Elheiga","year":"2001","journal-title":"Science"}],"container-title":["Current Opinion in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166901002713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166901002713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T03:09:41Z","timestamp":1578452981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958166901002713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0958166901002713"],"URL":"https:\/\/doi.org\/10.1016\/s0958-1669(01)00271-3","relation":{},"ISSN":["0958-1669"],"issn-type":[{"value":"0958-1669","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}